Ir para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Palavra solta
Título
Autor
Assunto
Área/Cota
ISBN/ISSN
Tag
Pesquisar
Avançada
Anti-OX40Ligand treatment as a...
Citar
Enviar por SMS
Enviar por email
Imprimir
Exportar registo
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Permanent link
Anti-OX40Ligand treatment as a novel therapeutic strategy in a murine model of colitis
Detalhes bibliográficos
Main Authors:
Singh, B
,
Malmstrom, V
,
Powrie, F
Formato:
Journal article
Publicado em:
2001
Exemplares
Descrição
Registos relacionados
Registo fonte
Registos relacionados
OX40 is required for regulatory T cell-mediated control of colitis.
Por: Griseri, T, et al.
Publicado em: (2010)
Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
Por: Ayaka Sato, et al.
Publicado em: (2025-01-01)
Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia
Por: Dawei Cui, et al.
Publicado em: (2019-01-01)
Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis
Por: Xiaoling Zhou, et al.
Publicado em: (2022-01-01)
OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.
Por: al-Shamkhani, A, et al.
Publicado em: (1996)